Literature DB >> 1308015

Wegener's granulomatosis: clinical experience with eighteen patients.

P Bambery1, V Sakhuja, S R Bhusnurmath, S K Jindal, S D Deodhar, K S Chugh.   

Abstract

Wegener's granulomatosis is being recognised with increasing frequency in India. Our 18, histologically confirmed, patients had a clinical profile similar to that described from developed countries. Delayed diagnosis led to the death of nine patients, usually within days of hospital admission, due to extensive vasculitis and renal failure. Tuberculosis was the most frequently considered diagnosis and 12 patients had been treated for it in spite of progressive clinical deterioration. Those who could be adequately treated with low dose daily cyclophosphamide and corticosteroids did well. Six of seven such patients are alive and well 1-8 years later. We believe that if prompt lung biopsy and ANCA determination are resorted to in patients with "resistant tuberculosis", it will greatly expedite case detection, diagnosis and optimum treatment of this remediable disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308015

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Wegener's Granulomatosis with Fungal Lung Infection in a Child.

Authors:  S S Mathai; K S Bawa; P S Tampi; A Bhandari; R N Mishra
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Immune deposits in cutaneous lesions of Wegener's granulomatosis: predictor of an active disease.

Authors:  Seema Chhabra; Ranjana W Minz; Lekha Rani; Nidhi Sharma; Vinay Sakhuja; Aman Sharma
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

3.  Pulmonary-renal syndromes: Experience from an Indian Intensive Care Unit.

Authors:  Srinivas Rajagopala; Baburao Kanthamani Pramod Sagar; Molly Mary Thabah; B H Srinivas; Ramanathan Venkateswaran; Sreejith Parameswaran
Journal:  Indian J Crit Care Med       Date:  2015-06

4.  Granulomatosis with polyangiitis: clinical course and outcome of 60 patients from a single center in South India.

Authors:  Vineeta Shobha; Saba Fathima; Ravi Prakash
Journal:  Clin Exp Med       Date:  2018-02-28       Impact factor: 3.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.